{
    "title": "Novartis trims sales outlook after hit from COVID disruptions",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8543847/Coronavirus-clouds-Novartiss-2020-outlook.html",
    "date": "2020-07-21",
    "keywords": [
        "novartis",
        "year",
        "narasimhan",
        "race",
        "covid19",
        "miller",
        "doctor",
        "johnson",
        "coronavirus",
        "percentage",
        "growth",
        "business",
        "development",
        "company",
        "vaccine",
        "drug",
        "tuesday",
        "hospital",
        "companys",
        "secondquarter",
        "revenue",
        "contrast",
        "group",
        "amp",
        "mix",
        "hit",
        "crisis",
        "cancer",
        "therapy",
        "lutathera",
        "eye",
        "lucentis",
        "xiidra",
        "contract",
        "unit",
        "sandoz",
        "income",
        "mid",
        "prevention",
        "research",
        "knowhow",
        "expertise",
        "hydroxychloroquine",
        "study",
        "addition",
        "absence",
        "corruption",
        "investor",
        "sentiment",
        "kantonalbank",
        "drop",
        "gmt",
        "reporting",
        "john",
        "editing",
        "louise",
        "heavensjason",
        "neelyjane",
        "merriman"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}